跳至主要内容
临床试验/CTRI/2024/12/078387
CTRI/2024/12/078387尚未招募3 期

A Clinical Study To Evaluate The Efficacy Of Aragwadhadi Kwath In The Management Of Vicharchika With Special Reference To Eczema.

Kunwar Shekhar Vijendra Ayurved Medical College And Research Centre Shobhit University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年1月6日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Reduction of sign and symptoms of eczema(Vicharchika).

研究概览

简要总结

The vounteer will be informed about the study protocol.

Willing participants will be randomly selected as per computer generated table.

The clinical research format will be validated.

Single arm study.

To assure the safety and efficacy of aragwadhadi kwath in the management of vicharchika(Eczema).

Drug are given to subjects in a group of 60 patients.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • 1 Subjects willing to sign the consent form.
  • 2 Subjects having clinical features of Kandu, Pidaka, Shyava and Bahusrava of Vicharchika will be included in the study.
  • 3 Subjects of both sexes in between 18 and 65 years of age 4 Eczema infections as per modern science Atopic dermatitis, Contact dermatitis, Statis dermatitis ,Seborrheic eczema will be included in this study.

排除标准

  • 1 Subjects not willing for clinical trial.
  • 2 Subject on steroids therapy and oral contraceptive therapy.
  • 3 Subjects less than 18 years and more than 65 years.
  • 4 Subjects with systemic disorders such as hypertension, diabetes mellitus, any carcinogenic disorder and HIV-positive patients.
  • 5 Subjects having signs and symptoms of other skin disorders such as TB skin, scabies.
  • 6 Undergone recent surgeries and taking immunosuppressive medicines.

结局指标

主要结局

Reduction of sign and symptoms of eczema(Vicharchika).

时间窗: 45 Days

次要结局

  • Cost effective treatment.(To observe if there is any adverse effect.)

研究者

发起方
Kunwar Shekhar Vijendra Ayurved Medical College And Research Centre Shobhit University
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Naman Sain

Kunwar Shekhar Vijendra Ayurved Medical College And Research Centre, Shobhit University.

研究点 (1)

Loading locations...

相似试验